Amrize Ltd (NYSE:AMRZ – Get Free Report) declared a dividend on Thursday, October 29th. Shareholders of record on Tuesday, November 10th will be given a dividend of $0.11 per share on Wednesday, November 18th. The ex-dividend date of this dividend is Tuesday, November 10th.
Amrize Stock Up 3.9%
Shares of Amrize stock traded up $1.57 on Thursday, hitting $41.60. The company had a trading volume of 10,295,852 shares, compared to its average volume of 3,441,747. The stock has a 50-day moving average of $39.86 and a 200-day moving average of $50.76. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.10 and a quick ratio of 0.73. Amrize has a twelve month low of $35.78 and a twelve month high of $65.94. The firm has a market capitalization of $23.01 billion, a P/E ratio of 19.17, a P/E/G ratio of 1.40 and a beta of 0.20.
Amrize (NYSE:AMRZ – Get Free Report) last issued its quarterly earnings results on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, meeting analysts’ consensus estimates of $1.05. The company had revenue of $3.77 billion for the quarter. Amrize had a return on equity of 10.22% and a net margin of 9.89%. The business’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.98 earnings per share. Research analysts predict that Amrize will post 2.44 earnings per share for the current year.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on AMRZ shares. William Blair set a $40.00 price target on shares of Amrize in a research note on Wednesday, September 2nd. JPMorgan Chase & Co. dropped their target price on Amrize from $52.00 to $48.00 and set a “neutral” rating on the stock in a report on Tuesday, October 13th. Wells Fargo & Company decreased their price objective on shares of Amrize from $44.00 to $40.00 and set an “equal weight” rating for the company in a research report on Monday, October 5th. Barclays dropped their price target on Amrize from $55.00 to $40.00 and set an “equal weight” rating on the stock in a research note on Monday, October 19th. Finally, Stephens cut their price objective on shares of Amrize from $65.00 to $54.00 and set an “overweight” rating for the company in a research report on Wednesday, August 12th. Eight analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $49.12.
Check Out Our Latest Research Report on AMRZ
Amrize Company Profile
Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.
The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.
Amrize was formed through the separation of Holcim’s North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.
Further Reading
- Five stocks we like better than Amrize
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
